# Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure

> **NCT01206504** · — · NO_LONGER_AVAILABLE · sponsor: **MacroGenics**

## Conditions studied

- West Nile Virus Infection

## Interventions

- **BIOLOGICAL:** MGAWN1

## Key facts

- **NCT ID:** NCT01206504
- **Lead sponsor:** MacroGenics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206504, "Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01206504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*